# Atea Pharmaceuticals, Inc.
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/atea-pharmaceuticals-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 33 |
| Claims under review | 1 |
| Evidence records | 9 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-22T04:46:27.103907+00:00 |
| Last reviewed | 2026-10-22T04:46:27.103907+00:00 |
## Identity
- Legal name: Atea Pharmaceuticals, Inc.
- Display name: Atea Pharmaceuticals, Inc.
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-22T06:34:13.28279+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.842 |
| Directors | 9 |
| Committees | 8 |
| Governance events | 26 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Arthur Kirsch: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:5
- Barbara Duncan: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:6
- Bruce W. Polsky, MD, MACP, FIDSA: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:7
- Bruno Lucidi: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:8
- Franklin Berger: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:9
- Howard H. Berman, PhD: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:10
- Jean-Pierre Sommadossi, PhD: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:11
- Jerome Adams, MD, MPH: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:12
- Polly A. Murphy, DVM, PhD: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:13
## Committees
- Audit (audit). Chair: Barbara Duncan. Members: Barbara Duncan (chair, current); Arthur Kirsch (member, current); Bruno Lucidi (member, current); Franklin Berger (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit
- Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Barbara Duncan (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-chair-nominating-and-governance
- Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Bruno Lucidi (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-compensation
- Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Franklin Berger (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-compensation-chair
- Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Arthur Kirsch (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:audit-nominating-and-governance
- Compensation (compensation). Chair: Franklin Berger. Members: Franklin Berger (chair, current); Bruce W. Polsky, MD, MACP, FIDSA (member, current); Bruno Lucidi (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:compensation
- Nominating and Governance (nominating_governance). Chair: Polly A. Murphy, DVM, PhD. Members: Polly A. Murphy, DVM, PhD (chair, current); Arthur Kirsch (member, current); Barbara Duncan (member, current); Jerome Adams, MD, MPH (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:nominating-and-governance
- Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Polly A. Murphy, DVM, PhD (member, current). committee_id=alpha:committee:atea-pharmaceuticals-inc:nominating-and-governance-chair
## Executive leadership
- Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary [CFO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:14
- Janet Hammond, M.D., Ph.D.: Chief Development Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:15
- Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:16
- John Vavricka: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:17
- Maria Arantxa Horga, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:18
- Wayne Foster: Executive Vice President and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:19
## Governance events
- CFO_CHANGED: Andrea Corcoran executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:26bdma1auw4zg
- EXECUTIVE_APPOINTED: Janet Hammond, M.D., Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:199g6dymly5ak
- CEO_CHANGED: Jean-Pierre Sommadossi, Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1pduv5igp5p7g
- EXECUTIVE_APPOINTED: John Vavricka executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1qp7z7lg9fgzv
- EXECUTIVE_APPOINTED: Maria Arantxa Horga, M.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1ozkzxx33w54r
- EXECUTIVE_APPOINTED: Wayne Foster executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1kwdfrtpgig2r
- DIRECTOR_APPOINTED: Arthur Kirsch seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1cjm4w218agkhs
- DIRECTOR_APPOINTED: Howard H. Berman, PhD seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1sk9kdigjyrto
- COMMITTEE_CREATED: Audit; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1x41vear6tgxk
- COMMITTEE_MEMBER_ADDED: Arthur Kirsch member of Audit; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:opswodjls8dd
- DIRECTOR_APPOINTED: Jerome Adams, MD, MPH seat on Atea Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:ljgrzwksidqq
- DIRECTOR_APPOINTED: Barbara Duncan seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:2z05pm1lyolnm
- DIRECTOR_APPOINTED: Polly A. Murphy, DVM, PhD seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:5mxee28wdxce
- COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1w8228ifyog8i
- COMMITTEE_MEMBER_ADDED: Barbara Duncan member of Audit · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:b2pp6v1fjjpaz
- COMMITTEE_CREATED: Nominating and Governance · Chair committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:9f43pe1r3wqqu
- COMMITTEE_MEMBER_ADDED: Polly A. Murphy, DVM, PhD member of Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1ugesp71qdgeu7
- DIRECTOR_APPOINTED: Franklin Berger seat on Atea Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:102j22x68atgz
- COMMITTEE_CREATED: Audit; Compensation · Chair committee of Atea Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:bcpem11i6maz
- COMMITTEE_MEMBER_ADDED: Franklin Berger member of Audit; Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1jeklhhrbj2q1
- DIRECTOR_APPOINTED: Bruce W. Polsky, MD, MACP, FIDSA seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1mb4f3419b7aa4
- DIRECTOR_APPOINTED: Bruno Lucidi seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1bi6oc1jgg3hr
- DIRECTOR_APPOINTED: Jean-Pierre Sommadossi, PhD seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:b1l0251grv7an
- COMMITTEE_CREATED: Audit; Compensation committee of Atea Pharmaceuticals, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:1nu6twx1efbssf
- COMMITTEE_MEMBER_ADDED: Bruno Lucidi member of Audit; Compensation, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:2ohtg71awoblp
- COMMITTEE_MEMBER_ADDED: Bruce W. Polsky, MD, MACP, FIDSA member of Compensation, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:27.103907+00:00. event_id=alpha:event:transition:rjeq2uh06ye
## Scoped resources
- `alpha://company/atea-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record
- `alpha://company/atea-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=identity
- `alpha://company/atea-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=corporate-structure
- `alpha://company/atea-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=board
- `alpha://company/atea-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=committees
- `alpha://company/atea-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=leadership
- `alpha://company/atea-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ownership
- `alpha://company/atea-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=financials
- `alpha://company/atea-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=capital-structure
- `alpha://company/atea-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=compensation
- `alpha://company/atea-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=governance
- `alpha://company/atea-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=shareholder-governance
- `alpha://company/atea-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=audit
- `alpha://company/atea-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=legal
- `alpha://company/atea-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=risk
- `alpha://company/atea-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=cyber
- `alpha://company/atea-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ai-governance
- `alpha://company/atea-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=agents
- `alpha://company/atea-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=ecosystem
- `alpha://company/atea-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=events
- `alpha://company/atea-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=relationships
- `alpha://company/atea-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=assessments
- `alpha://company/atea-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:barbara-duncan","name":"Barbara Duncan"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:arthur-kirsch","name":"Arthur Kirsch"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:bruno-lucidi","name":"Bruno Lucidi"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:franklin-berger","name":"Franklin Berger"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:franklin-berger","name":"Franklin Berger"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:bruce-w-polsky-md-macp-fidsa","name":"Bruce W. Polsky, MD, MACP, FIDSA"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:bruno-lucidi","name":"Bruno Lucidi"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:polly-a-murphy-dvm-phd","name":"Polly A. Murphy, DVM, PhD"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:arthur-kirsch","name":"Arthur Kirsch"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:barbara-duncan","name":"Barbara Duncan"},"source_id":"board_seats"}`
- Claim alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jerome-adams-md-mph","name":"Jerome Adams, MD, MPH"},"source_id":"board_seats"}`
## Leadership
- Arthur Kirsch: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Barbara Duncan: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Bruce W. Polsky, MD, MACP, FIDSA: Director, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Bruno Lucidi: Director, Audit; Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:8. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Franklin Berger: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Howard H. Berman, PhD: Director. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Jean-Pierre Sommadossi, PhD: Director. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:11. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Jerome Adams, MD, MPH: Director, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Polly A. Murphy, DVM, PhD: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168.
- Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:14. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9953e8211c98d4f1db61fe1f2c32217765f41f532ecf501efc46ef5032f59c9d.
- Janet Hammond, M.D., Ph.D.: Chief Development Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:15. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:40cc738b5fbd3fa003b7c1829117fe79cd6a470b7c94e2517c01938d7c88459f.
- Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:16. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c16946c22a0f7642cf389ef5571c6bde253d8c4508114ec8ab1999b8c832ccd0.
- John Vavricka: Chief Commercial Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:17. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9ff6707f20fd707526e2ce84ab2a965565c356ba38434025f7493e71883eb924.
- Maria Arantxa Horga, M.D.: Chief Medical Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:18. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b2f3451aaeeb0f8396e6762730cb2743b7b44148603ba57c10f06133a7bfd2c6.
- Wayne Foster: Executive Vice President and Chief Accounting Officer. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:19. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:384f36b2791a1c51feaabbd002b0117f0ae301c9489f9a564efeff6ea674a775.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair Barbara Duncan; Members Barbara Duncan (Chair); Arthur Kirsch; Bruno Lucidi; Franklin Berger. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Compensation: Chair Franklin Berger; Members Franklin Berger (Chair); Bruce W. Polsky, MD, MACP, FIDSA; Bruno Lucidi. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Nominating and Governance: Chair Polly A. Murphy, DVM, PhD; Members Polly A. Murphy, DVM, PhD (Chair); Arthur Kirsch; Barbara Duncan; Jerome Adams, MD, MPH. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_record:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- Atea Pharmaceuticals, Inc.. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5.
## Entity Status
- Public listing published. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5.
## Published Fact
- US. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5.
## Committee Appointment
- Barbara Duncan: chair, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Arthur Kirsch: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Bruno Lucidi: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Franklin Berger: member, Audit. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Franklin Berger: chair, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Bruce W. Polsky, MD, MACP, FIDSA: member, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Bruno Lucidi: member, Compensation. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Polly A. Murphy, DVM, PhD: chair, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Arthur Kirsch: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Barbara Duncan: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
- Jerome Adams, MD, MPH: member, Nominating and Governance. Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab.
## Security Listing
- AVIR (NASDAQ). Claim: alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:security_listing:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:3c1e89afa4e1533f447d3f2ca5262abc82d5d72c421b456760bf7afce730f1c5: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc).
- alpha:projection-evidence:document:a4700459dfc77ee8a7c9a0cb0af22f79475f321f8ed32f9ddacb4c85a1b02168: [Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm).
- alpha:projection-evidence:document:9953e8211c98d4f1db61fe1f2c32217765f41f532ecf501efc46ef5032f59c9d: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:document:40cc738b5fbd3fa003b7c1829117fe79cd6a470b7c94e2517c01938d7c88459f: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:document:c16946c22a0f7642cf389ef5571c6bde253d8c4508114ec8ab1999b8c832ccd0: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:document:9ff6707f20fd707526e2ce84ab2a965565c356ba38434025f7493e71883eb924: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:document:b2f3451aaeeb0f8396e6762730cb2743b7b44148603ba57c10f06133a7bfd2c6: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:document:384f36b2791a1c51feaabbd002b0117f0ae301c9489f9a564efeff6ea674a775: [AVIR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm).
- alpha:projection-evidence:c432ae6d9a0461669f32d7d030cdc37c429f1fbb12b21eb8902c0a6f091160ab: [Audit](https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/atea-pharmaceuticals-inc)
- [Public Markdown](https://registry.alpha.ac/companies/atea-pharmaceuticals-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=jsonld)
- MCP resource: `alpha://companies/atea-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-22T06:34:12.97118+00:00; recorded 2026-10-22T06:34:12.97118+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.Atea Pharmaceuticals, Inc., for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 22, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 22, 2026. Reviewed Oct 22, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/atea-pharmaceuticals-incTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/atea-pharmaceuticals-incalpha://companies/atea-pharmaceuticals-incThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
CFO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)EXECUTIVE_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)CEO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.CFO_CHANGED",
"source": "https://registry.alpha.ac/companies/atea-pharmaceuticals-inc",
"subject": "alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Andrea Corcoran executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Janet Hammond, M.D., Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Jean-Pierre Sommadossi, Ph.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | John Vavricka executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Maria Arantxa Horga, M.D. executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 5, 2026 | Oct 22, 2026 | Not yet signed | Not yet signed | Wayne Foster executive of Atea Pharmaceuticals, Inc., effective 2026-03-05. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 22, 2026 | Not yet signed | Not yet signed | Arthur Kirsch seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 22, 2026 | Not yet signed | Not yet signed | Howard H. Berman, PhD seat on Atea Pharmaceuticals, Inc., effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 22, 2026 | Not yet signed | Not yet signed | Audit; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 22, 2026 | Not yet signed | Not yet signed | Arthur Kirsch member of Audit; Nominating and Governance, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 22, 2026 | Not yet signed | Not yet signed | Jerome Adams, MD, MPH seat on Atea Pharmaceuticals, Inc., effective 2021-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Barbara Duncan seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Polly A. Murphy, DVM, PhD seat on Atea Pharmaceuticals, Inc., effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Audit · Chair; Nominating and Governance committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Barbara Duncan member of Audit · Chair; Nominating and Governance, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Nominating and Governance · Chair committee of Atea Pharmaceuticals, Inc., effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 22, 2026 | Not yet signed | Not yet signed | Polly A. Murphy, DVM, PhD member of Nominating and Governance · Chair, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Franklin Berger seat on Atea Pharmaceuticals, Inc., effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Audit; Compensation · Chair committee of Atea Pharmaceuticals, Inc., effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 22, 2026 | Not yet signed | Not yet signed | Franklin Berger member of Audit; Compensation · Chair, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Bruce W. Polsky, MD, MACP, FIDSA seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Bruno Lucidi seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Jean-Pierre Sommadossi, PhD seat on Atea Pharmaceuticals, Inc., effective 2014-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Audit; Compensation committee of Atea Pharmaceuticals, Inc., effective 2014-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Bruno Lucidi member of Audit; Compensation, effective 2014-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2014 | Oct 22, 2026 | Not yet signed | Not yet signed | Bruce W. Polsky, MD, MACP, FIDSA member of Compensation, effective 2014-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 9,
"redistribution_allowed": 0,
"restricted_or_unknown": 9,
"classified_unknown": 9
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/llms-full.txtAlpha consolidated public agent guide/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 10 |
| Committees | #c-committees | /committees | Published | 14 |
| Leadership | #c-leadership | /leadership | Published | 5 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 1 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Not reviewed | - |
| Events | #c-history | /events | Published | 26 |
| Relationships | #c-links | /relationships | Published | 15 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 9 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



